The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Akero Therapeutics Inc (NASDAQ: AKRO) closed at $42.79 up 1.83% from its previous closing price of $42.02. In other words, the price has increased by $1.83 from its previous closing price. On the day, 0.98 million shares were traded.
Ratios:
For a deeper understanding of Akero Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.38 and its Current Ratio is at 19.38. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 06 ’25 when Timothy Rolph bought 50,000 shares for $40.00 per share.
Rolph Timothy sold 6,250 shares of AKRO for $256,438 on Apr 24 ’25. The Chief Scientific Officer now owns 169,721 shares after completing the transaction at $41.03 per share. On Apr 15 ’25, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 9,073 shares for $37.91 each. As a result, the insider received 343,962 and left with 95,034 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $17.86. The 50-Day Moving Average of the stock is 1.71%, while the 200-Day Moving Average is calculated to be 25.12%.
Shares Statistics:
A total of 72.38M shares are outstanding, with a floating share count of 70.76M. Insiders hold about 11.19% of the company’s shares, while institutions hold 88.16% stake in the company.
